By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biovest International, Inc. 

Corporate Headquarters
8500 Evergreen Blvd. NW
Minneapolis  Minnesota  55433  U.S.A.
Phone: 763-786-0302 Fax: 763-786-0915



Company News
Stellar Biotechnologies, Inc. And Biovest International, Inc. Sign KLH Supply Agreement For BiovaxID Immunotherapy For Follicular Non-Hodgkin's Lymphoma 10/24/2014 11:47:51 AM
Biovest International, Inc. CEO Carlos F. Santos, Ph.D. To Present At The Phacilitate Immunotherapy Forum 1/27/2014 9:30:09 AM
European Medicines Agency Accepts Marketing Authorization Application For Biovest International, Inc.’s Cancer Vaccine For Treatment Of Non-Hodgkin’s Follicular Lymphoma 1/13/2014 10:57:09 AM
Biovest International, Inc. Emerges From Bankruptcy and Taps New CEO 7/16/2013 7:04:30 AM
Request to Appoint Tustee or Examiner in Biovest International, Inc. Case Denied 4/16/2013 8:58:43 AM
Biovest International, Inc. Files for Bankruptcy 3/8/2013 8:20:58 AM
Accentia Biopharmaceuticals (ABPI), Biovest International, Inc. Shrink Losses, Default on Debt 12/27/2012 8:16:32 AM
Biovest International, Inc. Names Lymphoma Key Opinion Leader From MD Anderson Cancer Center to Scientific Advisory Board 9/11/2012 10:13:57 AM
Biovest International, Inc. Conducts End of Phase III Review With FDA of BiovaxID™ as Consolidation Therapy in Non-Hodgkin's Lymphoma 8/14/2012 9:03:40 AM
Biovest International, Inc. Advances Process Seeking European Marketing Approval for BiovaxID™ Personalized Lymphoma Vaccine 7/30/2012 10:02:38 AM